LAVA Medtech Acquisition Corp. Warrants
LVACW
LVACW was delisted on the 12th of May, 2023.
33 hedge funds and large institutions have $487K invested in LAVA Medtech Acquisition Corp. Warrants in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 33 → 33 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
44% less capital invested
Capital invested by funds: $867K → $487K (-$380K)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$2.75K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$1.84K |
| 3 |
GAM
Gritstone Asset Management
Bethesda,
Maryland
|
+$1.04K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$32 |
| 5 |
CS
Clear Street
New York
|
+$27 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG
StoneX Group
New York
|
-$3.14K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$236 |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$51 |
| 4 |
SC
Sculptor Capital
New York
|
-$46 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Walleye Trading
New York
| $2.02K | – | – | – |
|
|
WA
27
Whitebox Advisors
Minneapolis,
Minnesota
| $1.88K | – | – | – |
|
|
SG
28
StoneX Group
New York
| $1.12K | -$3.14K | -57,423 | -74% |
|
29
Calamos Advisors
Naperville,
Illinois
| $1.06K | – | – | – |
|
|
DCM
30
Dupont Capital Management
Wilmington,
Delaware
| $424 | – | – | – |
|
|
AA
31
Ancora Advisors
Cleveland,
Ohio
| $143 | – | – | – |
|
|
CS
32
Clear Street
New York
| $38 | +$27 | +500 | New |
|
|
33
UBS Group
Zurich,
Switzerland
| $32 | +$32 | +590 | New |
|
LVACW Hedge Fund Activity: Q1 2023 in Review
33 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Warrants (LVACW) for Q1 2023, worth a combined $487K — down 44% from $867K a quarter earlier.
Fund positioning in LVACW was balanced in Q1 2023: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 4 trimmed.
The largest buyer was Cowen and Company, opening a new position worth an estimated $2.75K. The largest seller was StoneX Group, cutting an estimated $3.14K.
- 33 institutional investors held LAVA Medtech Acquisition Corp. Warrants (LVACW) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $487K of LAVA Medtech Acquisition Corp. Warrants stock for Q1 2023, down 44% quarter-over-quarter.
- 3 funds opened new LAVA Medtech Acquisition Corp. Warrants positions in Q1 2023 and 3 closed out, a net change of 0 holders.
- The largest LAVA Medtech Acquisition Corp. Warrants buyer in Q1 2023 was Cowen and Company, an estimated $2.75K added.
- The largest LAVA Medtech Acquisition Corp. Warrants seller in Q1 2023 was StoneX Group, an estimated $3.14K sold.
Based on aggregated 13F filings for Q1 2023.